MG Pharma Inc.
Records under this name other than patents MG Pharma Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to MG Pharma Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,691,949 | Peptide having anti-diabetic activity and use thereof Lapsed on the fee record Ended Apr 8, 2022 · From the USPTO record | Lapsed on the fee record | Ended Apr 8, 2022 | From the USPTO record |
| US 8,394,769 | Anti-hypertensive agent Lapsed on the fee record Ended Mar 12, 2021 · From the USPTO record | Lapsed on the fee record | Ended Mar 12, 2021 | From the USPTO record |
| US 8,357,776 | Composition for suppressing re-elevation of cholesterol, and usage thereof Lapsed on the fee record Ended Jan 22, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jan 22, 2021 | From the USPTO record |
| US 6,046,168 | Peptide inhibits blood triglyceride level Lapsed on the fee record Ended Apr 4, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 4, 2012 | From the USPTO record |
| US 5,723,443 | Lipid metabolism promoting agent and its use Term ended Term ended no later than Mar 3, 2018 · Low confidence | Term ended | Term ended no later than Mar 3, 2018 | Low confidence |
| US 5,756,467 | Adipocyte differentiation inhibiting peptide and adipocyte differentiation inhibiting agent using the peptide as active component thereof Term ended Term ended no later than May 26, 2018 · Low confidence | Term ended | Term ended no later than May 26, 2018 | Low confidence |
| US 5,958,885 | Peptide and formulations thereof inhibiting elevations of triglyceride levels in blood Formerly held Term ended Term ended no later than Sep 28, 2019 · Low confidence | Term ended | Term ended no later than Sep 28, 2019 | Low confidence |